Background COVID-19 is characterised by respiratory symptoms, which deteriorate into
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a third of …

Asian series have shown a 5‐year survival rate of ≈70% after resection of hepatocellular
carcinoma (HCC) ≤2 cm. Western outcomes with resection have not been as good. In addition…

SARS2‐CoV‐2 breakout in Italy caused a huge number of severely ill patients with a serious
increase in mortality. Although lungs seem to be the main target of the infection, very few …

Purpose: Refining the selection of HER2-positive metastatic gastric cancer patient candidates
for trastuzumab is a challenge of precision oncology. Preclinical studies have suggested …

BACKGROUND & AIMS: The advent of molecular medicine that targets specific pathways is
changing the therapeutic approach to hepatocellular carcinoma. For several aberrantly …

Purpose To evaluate the short-term safety and efficacy of the new generation of 70–150 µm
drug-eluting beads (M1 DEB) in patients with hepatocellular carcinoma undergoing …

Currently, therapeutic management of gastric cancer is mainly based on clinical data and
histological features. Although several new treatment options have recently been introduced, …

Papillary thyroid carcinomas (PTCs) in pediatric age show an excellent outcome, independently
of sex, stage at diagnosis, occurrence of relapse, and type of treatment. Our aim was to …

A correlation between osteopontin, E-cadherin, β-catenin, and cyclooxygenase 2 overexpression
and poor clinicopathological features and prognosis has been previously suggested in …

Background Patients with high microsatellite instability (MSI) gastric cancer (GC) show improved
survival and no benefit or harm from adjuvant and/or perioperative chemotherapy. The …